Semaglutide
5 mg
GLP-1 Receptor Agonist (Ozempic analogue)
Semaglutide
GLP-1 receptor agonist for metabolic and appetite regulation research.
Prices in AUD. Tax included.
Research Use Only: FOR LABORATORY RESEARCH USE ONLY. Not for human consumption, injection, or therapeutic use. All products are sold strictly as research chemicals. By purchasing, you confirm you are 18+ and agree to use products solely for legitimate research purposes.
Description
Semaglutide is a synthetic GLP-1 receptor agonist peptide widely studied for its role in glucose homeostasis and appetite regulation. Research has demonstrated significant effects on metabolic pathways involved in energy balance. It is one of the most extensively researched peptides in the GLP-1 class, with numerous published studies on its pharmacokinetic profile.
Specifications
- SKU
- SEMA-5MG
- Size
- 5 mg
- Form
- Lyophilised Powder
- Purity
- >99%
- Storage
- -20°C (lyophilised), 2-8°C (reconstituted)
- Shipping
- Australia Post — 3–5 business days
Research Summary
Published research indicates Semaglutide binds to GLP-1 receptors with high affinity, activating cAMP signaling pathways. Studies in animal models have shown dose-dependent effects on food intake reduction and improved insulin sensitivity. Half-life studies suggest extended duration of action compared to native GLP-1.
Testing Protocol
- HPLC Purity Analysis
- Mass Spectrometry Identity Verification
- Endotoxin Screening (LAL Test)